New biotech patent makes Spirulina microalgae into a specialty chemical factory

New biotech patent makes Spirulina microalgae into a specialty chemical factory


Lumen Bioscience announced today that the US Patent and Trademark Office has issued a patent for its gene editing and insertion technology that makes the microorganism into a platform that can readily produce biologics, proteins, and other various molecules at commercial scale-some of which are in line to be used in cosmetics and personal care manufacturing. When working with microorganisms like bacteria, fungi, and algae, rather than using plant breeding to changes traits, scientists adjust and edit genes directly.



from Biotech News
Share:

Комментариев нет:

Отправить комментарий

Pharmacy News Digest

Архив блога